FLNA 8-K 2026-11-05

FILANA THERAPEUTICS, INC. (FLNA) 8-K dated 2026-11-05 — accession 0001171843-26-007150.

FILANA THERAPEUTICS, INC. (FLNA) common stock.

FLNA: Filana Therapeutics Reports Q3 2026 Financial Results and Provides Busi…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for FLNA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The FLNA SEC hub lists recent forms. The stock page is the research view.